Pay in 4 interest-free payments of $6.05 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Your review * I am very glad I chose Vitastir
What they found: In normal obese mice: AOD-9604 reduced body fat by 21 % vs placebo, hGH by 24 % The AOD-9604 effect was fully dependent on the 3-adrenergic receptor , in knock-out mice no effect The hGH effect was partly independent of 3-AR , in knock-out mice there was still ~10 % fat reduction AOD-9604 did not raise IGF-1 (control level), whereas hGH raised IGF-1 by 80 % No changes in growth, organ weights (except adipose tissue), fasting insulin Why it matters: The study provided the mechanistic basis for AOD-9604 and confirmed the key business hypothesis: it is possible to separate the lipolytic effect of GH from its growth effect
Triple Agonist Mechanism: GIP, GLP-1, and Glucagon Phase 2 Clinical Trial Data Phase 3 TRIUMPH Program Status Dosing Research Parameters Reconstitution: 5 mg and 30 mg Vials Storage and Stability Protocols Retatrutide vs
Need help deciding if AOD 9604 is right for you
